Report Detail

Request for Sample of this report

Other Global Human Fibrinogen Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM2880226
    • |
  • 17 April, 2023
    • |
  • Global
    • |
  • 115 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
According to our (Global Info Research) latest study, the global Human Fibrinogen market size was valued at USD 818.8 million in 2022 and is forecast to a readjusted size of USD 2156.1 million by 2029 with a CAGR of 14.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.
This report is a detailed and comprehensive analysis for global Human Fibrinogen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Fibrinogen market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029
Global Human Fibrinogen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029
Global Human Fibrinogen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2018-2029
Global Human Fibrinogen market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Fibrinogen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Fibrinogen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical and Hualan Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Fibrinogen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Market segment by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
Major players covered
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Fibrinogen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Fibrinogen, with price, sales, revenue and global market share of Human Fibrinogen from 2018 to 2023.
Chapter 3, the Human Fibrinogen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Fibrinogen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Fibrinogen market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Fibrinogen.
Chapter 14 and 15, to describe Human Fibrinogen sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Human Fibrinogen
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Human Fibrinogen Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Human Fibrinogen Concentrate
    • 1.3.3 Animal Fibrinogen Concentrate
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Human Fibrinogen Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Congenital Fibrinogen Deficiency
    • 1.4.3 Surgical Procedures
  • 1.5 Global Human Fibrinogen Market Size & Forecast
    • 1.5.1 Global Human Fibrinogen Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Human Fibrinogen Sales Quantity (2018-2029)
    • 1.5.3 Global Human Fibrinogen Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 CSL Behring
    • 2.1.1 CSL Behring Details
    • 2.1.2 CSL Behring Major Business
    • 2.1.3 CSL Behring Human Fibrinogen Product and Services
    • 2.1.4 CSL Behring Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 CSL Behring Recent Developments/Updates
  • 2.2 LFB Group
    • 2.2.1 LFB Group Details
    • 2.2.2 LFB Group Major Business
    • 2.2.3 LFB Group Human Fibrinogen Product and Services
    • 2.2.4 LFB Group Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 LFB Group Recent Developments/Updates
  • 2.3 Shanghai RAAS Blood Products
    • 2.3.1 Shanghai RAAS Blood Products Details
    • 2.3.2 Shanghai RAAS Blood Products Major Business
    • 2.3.3 Shanghai RAAS Blood Products Human Fibrinogen Product and Services
    • 2.3.4 Shanghai RAAS Blood Products Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
  • 2.4 Jiangxi Boya Bio-Pharmaceutical
    • 2.4.1 Jiangxi Boya Bio-Pharmaceutical Details
    • 2.4.2 Jiangxi Boya Bio-Pharmaceutical Major Business
    • 2.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product and Services
    • 2.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments/Updates
  • 2.5 Hualan Biological Engineering
    • 2.5.1 Hualan Biological Engineering Details
    • 2.5.2 Hualan Biological Engineering Major Business
    • 2.5.3 Hualan Biological Engineering Human Fibrinogen Product and Services
    • 2.5.4 Hualan Biological Engineering Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Hualan Biological Engineering Recent Developments/Updates
  • 2.6 Harbin Pacific Biopharmaceutical
    • 2.6.1 Harbin Pacific Biopharmaceutical Details
    • 2.6.2 Harbin Pacific Biopharmaceutical Major Business
    • 2.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Product and Services
    • 2.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Harbin Pacific Biopharmaceutical Recent Developments/Updates
  • 2.7 GREEN CROSS
    • 2.7.1 GREEN CROSS Details
    • 2.7.2 GREEN CROSS Major Business
    • 2.7.3 GREEN CROSS Human Fibrinogen Product and Services
    • 2.7.4 GREEN CROSS Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 GREEN CROSS Recent Developments/Updates
  • 2.8 Shanghai XinXing Medical
    • 2.8.1 Shanghai XinXing Medical Details
    • 2.8.2 Shanghai XinXing Medical Major Business
    • 2.8.3 Shanghai XinXing Medical Human Fibrinogen Product and Services
    • 2.8.4 Shanghai XinXing Medical Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Shanghai XinXing Medical Recent Developments/Updates
  • 2.9 Octapharma
    • 2.9.1 Octapharma Details
    • 2.9.2 Octapharma Major Business
    • 2.9.3 Octapharma Human Fibrinogen Product and Services
    • 2.9.4 Octapharma Human Fibrinogen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Octapharma Recent Developments/Updates

3 Competitive Environment: Human Fibrinogen by Manufacturer

  • 3.1 Global Human Fibrinogen Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Human Fibrinogen Revenue by Manufacturer (2018-2023)
  • 3.3 Global Human Fibrinogen Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Human Fibrinogen by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Human Fibrinogen Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Human Fibrinogen Manufacturer Market Share in 2022
  • 3.5 Human Fibrinogen Market: Overall Company Footprint Analysis
    • 3.5.1 Human Fibrinogen Market: Region Footprint
    • 3.5.2 Human Fibrinogen Market: Company Product Type Footprint
    • 3.5.3 Human Fibrinogen Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Human Fibrinogen Market Size by Region
    • 4.1.1 Global Human Fibrinogen Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Human Fibrinogen Consumption Value by Region (2018-2029)
    • 4.1.3 Global Human Fibrinogen Average Price by Region (2018-2029)
  • 4.2 North America Human Fibrinogen Consumption Value (2018-2029)
  • 4.3 Europe Human Fibrinogen Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Human Fibrinogen Consumption Value (2018-2029)
  • 4.5 South America Human Fibrinogen Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Human Fibrinogen Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Human Fibrinogen Sales Quantity by Type (2018-2029)
  • 5.2 Global Human Fibrinogen Consumption Value by Type (2018-2029)
  • 5.3 Global Human Fibrinogen Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Human Fibrinogen Sales Quantity by Application (2018-2029)
  • 6.2 Global Human Fibrinogen Consumption Value by Application (2018-2029)
  • 6.3 Global Human Fibrinogen Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Human Fibrinogen Sales Quantity by Type (2018-2029)
  • 7.2 North America Human Fibrinogen Sales Quantity by Application (2018-2029)
  • 7.3 North America Human Fibrinogen Market Size by Country
    • 7.3.1 North America Human Fibrinogen Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Human Fibrinogen Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Human Fibrinogen Sales Quantity by Type (2018-2029)
  • 8.2 Europe Human Fibrinogen Sales Quantity by Application (2018-2029)
  • 8.3 Europe Human Fibrinogen Market Size by Country
    • 8.3.1 Europe Human Fibrinogen Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Human Fibrinogen Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Human Fibrinogen Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Human Fibrinogen Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Human Fibrinogen Market Size by Region
    • 9.3.1 Asia-Pacific Human Fibrinogen Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Human Fibrinogen Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Human Fibrinogen Sales Quantity by Type (2018-2029)
  • 10.2 South America Human Fibrinogen Sales Quantity by Application (2018-2029)
  • 10.3 South America Human Fibrinogen Market Size by Country
    • 10.3.1 South America Human Fibrinogen Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Human Fibrinogen Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Human Fibrinogen Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Human Fibrinogen Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Human Fibrinogen Market Size by Country
    • 11.3.1 Middle East & Africa Human Fibrinogen Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Human Fibrinogen Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Human Fibrinogen Market Drivers
  • 12.2 Human Fibrinogen Market Restraints
  • 12.3 Human Fibrinogen Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Human Fibrinogen and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Human Fibrinogen
  • 13.3 Human Fibrinogen Production Process
  • 13.4 Human Fibrinogen Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Human Fibrinogen Typical Distributors
  • 14.3 Human Fibrinogen Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Human Fibrinogen . Industry analysis & Market Report on Human Fibrinogen is a syndicated market report, published as Global Human Fibrinogen Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Human Fibrinogen market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,745.72
    		4,118.58
    		5,491.44
    		3,201.60
    		4,802.40
    		6,403.20
    		539,991.60
    		809,987.40
    		1,079,983.20
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo